Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
D000368:Aged; D001925:Brain Damage, Chronic / Q000209:etiology; D002746:Chlorpromazine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000209:etiology*; D010546:Perphenazine / Q000009:adverse effects*; D013881:Thioridazine / Q000009:adverse effects*; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014268:Trifluoperazine / Q000009:adverse effects*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D014282:Trihexyphenidyl; D010546:Perphenazine; D013881:Thioridazine; D002746:Chlorpromazine